The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study
-
- J. Bousquet
- MACVIA‐France Contre les MAladies Chroniques Pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site Montpellier France
-
- S. Arnavielhe
- Kyomed Montpellier France
-
- A. Bedbrook
- MACVIA‐France Contre les MAladies Chroniques Pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site Montpellier France
-
- J. Fonseca
- Faculdade de Medicina Center for Health Technology and Services Research‐ CINTESIS Universidade do Porto Porto Portugal
-
- M. Morais Almeida
- Allergy Center CUF‐Descobertas Hospital Lisboa Portugal
-
- A. Todo Bom
- Faculty of Medicine Imunoalergologia Centro Hospitalar Universitário de Coimbra University of Coimbra Coimbra Portugal
-
- I. Annesi‐Maesano
- EPAR U707 INSERM, Paris and EPAR UMR‐S UPMC, Paris VI Paris France
-
- D. Caimmi
- UPMC Paris 06, UMR‐S 1136, IPLESP, Equipe EPAR CHRU de Montpellier Sorbonne Universités Paris France
-
- P. Demoly
- UPMC Paris 06, UMR‐S 1136, IPLESP, Equipe EPAR CHRU de Montpellier Sorbonne Universités Paris France
-
- P. Devillier
- Laboratoire de Pharmacologie Respiratoire UPRES EA220 Pôle des Maladies Respiratoires Hôpital Foch Université Versailles Saint‐Quentin Suresnes France
-
- V. Siroux
- INSERM, IAB, U 1209 Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health Université Joseph Fourier Université Grenoble Alpes Grenoble France
-
- E. Menditto
- CIRFF Center of Pharmacoeconomics University of Naples Federico II Naples Italy
-
- G. Passalacqua
- Personalized Medicine Clinic Asthma & Allergy Humanitas Research Hospital Humanitas University Milan Italy
-
- C. Stellato
- Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana” University of Salerno Salerno Italy
-
- M. T. Ventura
- Unit of Geriatric Immunoallergology University of Bari Medical School Bari Italy
-
- A. A. Cruz
- ProAR – Nucleo de Excelencia em Asma, Brasil and GARD Executive Committee Federal University of Bahia Salvador Brazil
-
- F. Sarquis Serpa
- Asthma Reference Center Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria Vitória Brazil
-
- J. da Silva
- Allergy Service University Hospital of Federal University of Santa Catarina (HU‐UFSC) Florianopolis Brazil
-
- D. Larenas‐Linnemann
- Center of Excellence in Asthma and Allergy Hospital Médica Sur México Mexico
-
- M. Rodriguez Gonzalez
- Pediatric Allergy and Clinical Immunology, Hospital Angeles Pedregal Mexico City Mexico
-
- M. T. Burguete Cabañas
- Centro Médico Zambrano Hellion Monterrey Mexico
-
- K. C. Bergmann
- Comprehensive Allergy‐Centre‐Charité Department of Dermatology and Allergy Charité ‐ Universitätsmedizin Berlin Berlin Germany
-
- T. Keil
- Institute of Social Medicine, Epidemiology and Health Economics Charité ‐ Universitätsmedizin Berlin Berlin Germany
-
- L. Klimek
- Center for Rhinology and Allergology Wiesbaden Germany
-
- R. Mösges
- Medical Faculty Institute of Medical Statistics, Informatics and Epidemiology University of Cologne Cologne Germany
-
- S. Shamai
- Medical Faculty Institute of Medical Statistics, Informatics and Epidemiology University of Cologne Cologne Germany
-
- T. Zuberbier
- Comprehensive Allergy‐Centre‐Charité Department of Dermatology and Allergy Charité ‐ Universitätsmedizin Berlin Berlin Germany
-
- M. Bewick
- iQ4U Consultants Ltd London UK
-
- D. Price
- Observational and Pragmatic Research Institute Singapore Singapore
-
- D. Ryan
- Allergy and Respiratory Research Group Usher Institute of Population Health Sciences and Informatics University of Edinburgh Edinburgh UK
-
- A. Sheikh
- Asthma UK Centre for Applied Research Centre of Medical Informatics Usher Institute of Population Health Sciences and Informatics The University of Edinburgh Edinburgh UK
-
- J. M. Anto
- Centre for Research in Environmental Epidemiology (CREAL) ISGLoBAL Barcelona Spain
-
- J. Mullol
- Allergy Center CUF‐Descobertas Hospital Lisboa Portugal
-
- A. Valero
- Pneumology and Allergy Department Hospital Clínic Clinical & Experimental Respiratory Immunoallergy IDIBAPS, CIBERES University of Barcelona Barcelona Spain
-
- T. Haahtela
- Skin and Allergy Hospital Helsinki University Hospital Helsinki Finland
-
- E. Valovirta
- Pneumology and Allergy Department Hospital Clínic Clinical & Experimental Respiratory Immunoallergy IDIBAPS, CIBERES University of Barcelona Barcelona Spain
-
- W. J. Fokkens
- Department of Otorhinolaryngology Academic Medical Centre Amsterdam the Netherlands
-
- P. Kuna
- Division of Internal Medicine, Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland
-
- B. Samolinski
- Department of Prevention of Environmental Hazards and Allergology Medical University of Warsaw Poland
-
- C. Bindslev‐Jensen
- Department of Dermatology and Allergy Centre Odense University Hospital Odense Research Center for Anaphylaxis (ORCA) Odense Denmark
-
- E. Eller
- Department of Dermatology and Allergy Centre Odense University Hospital Odense Research Center for Anaphylaxis (ORCA) Odense Denmark
-
- S. Bosnic‐Anticevich
- Woolcock Institute of Medical Research University of Sydney and Sydney Local Health District Glebe NSW Australia
-
- R. E. O'Hehir
- Department of Allergy, Immunology and Respiratory Medicine Alfred Hospital and Central Clinical School Monash University Melbourne VIC Australia
-
- P. V. Tomazic
- Department of ENT Medical University of Graz Graz Austria
-
- A. Yorgancioglu
- Department of Pulmonology Celal Bayar University Manisa Turkey
-
- B. Gemicioglu
- Cerrahpasa Faculty of Medicine Department of Pulmonary Diseases Istanbul University Istanbul Turkey
-
- C. Bachert
- Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium
-
- P. W. Hellings
- Laboratory of Clinical Immunology Department of Microbiology and Immunology KU Leuven Leuven Belgium
-
- I. Kull
- Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Sweden
-
- E. Melén
- Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Sweden
-
- M. Wickman
- Sachs’ Children and Youth Hospital Södersjukhuset, Stockholm and Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
-
- M. van Eerd
- Peercode DV Gerdermalsen the Netherlands
-
- G. De Vries
- Peercode DV Gerdermalsen the Netherlands
抄録
<jats:title>Abstract</jats:title><jats:p>Mobile technology has been used to appraise allergic rhinitis control, but more data are needed. To better assess the importance of mobile technologies in rhinitis control, the <jats:styled-content style="fixed-case">ARIA</jats:styled-content> (Allergic Rhinitis and its Impact on Asthma) score ranging from 0 to 4 of the <jats:italic>Allergy Diary</jats:italic> was compared with <jats:styled-content style="fixed-case">EQ</jats:styled-content>‐5D (EuroQuol) and <jats:styled-content style="fixed-case">WPAI</jats:styled-content>‐<jats:styled-content style="fixed-case">AS</jats:styled-content> (Work Productivity and Activity Impairment in allergy) in 1288 users in 18 countries. This study showed that quality‐of‐life data (<jats:styled-content style="fixed-case">EQ</jats:styled-content>‐5D visual analogue scale and <jats:styled-content style="fixed-case">WPA</jats:styled-content>‐<jats:styled-content style="fixed-case">IS</jats:styled-content> Question 9) are similar in users without rhinitis and in those with mild rhinitis (scores 0‐2). Users with a score of 3 or 4 had a significant impairment in quality‐of‐life questionnaires.</jats:p>
収録刊行物
-
- Allergy
-
Allergy 73 (2), 505-510, 2017-10-05
Wiley